Erste Asset Management Gmb H Forma Therapeutics Holdings, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 26, 2024
SELL
N/A
-10,400 Closed
0 $0
Q4 2022

Nov 26, 2024
SELL
$0.0 - $20.01 $0 - $208,104
-10,400 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$7.12 - $20.24 $74,048 - $210,495
10,400 New
10,400 $207 Million
Q2 2022

Nov 26, 2024
BUY
$5.1 - $10.0 $53,039 - $104,000
10,400 New
10,400 $75.2 Million
Q4 2021

Nov 22, 2024
BUY
$13.6 - $24.89 $141,440 - $258,856
10,400 New
10,400 $145 Million
Q4 2020

Nov 22, 2024
BUY
$34.9 - $51.08 $362,960 - $531,232
10,400 New
10,400 $379 Million

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email